Access cutting-edge small-cell lung cancer treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access small-cell lung cancer specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small-cell lung cancer treatment provided free
The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS).
Sponsor: Amgen
Check if you qualify for this small-cell lung cancer clinical trial in New Haven, CT
If you're searching for small-cell lung cancer treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small-cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.